News from astellas pharma us, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:MDVN,Tokyo:4503,OTC-PINK:ALPMY)

Jan 26, 2016, 16:10 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Journal of Clinical Oncology Publishes Results from the STRIVE trial of enzalutamide Compared to bicalutamide in Castration-resistant Prostate Cancer

 Astellas US LLC, a United States (U.S.) subsidiary of Tokyo-based Astellas Pharma Inc. (TSE: 4503), and Medivation, Inc. (Nasdaq: MDVN) today...

Jan 22, 2016, 08:52 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics

 Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Ocata Therapeutics, Inc. (NASDAQ: OCAT, President and...

Jan 13, 2016, 14:37 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Agrees to PGA TOUR Sponsorship through 2020

 The PGA TOUR and Astellas Pharma today announced new initiatives to engage golf fans and non-fans alike with a five-year extension of their...

Dec 17, 2015, 15:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas to Present at J.P. Morgan Healthcare Conference

 Astellas Pharma today announced that the company's President and CEO Yoshihiko Hatanaka will present at the 34th Annual J.P. Morgan...

Dec 06, 2015, 16:30 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Announces Updated Data from the Phase 1/2 CHRYSALIS Trial for Gilteritinib (ASP2215) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Astellas US, LLC, a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced that updated data from the Phase 1/2 CHRYSALIS...

Nov 17, 2015, 10:20 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Announces New Data to be Presented at the 2015 ASH Annual Meeting

 Astellas US, LLC, a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced several abstracts, including an oral...

Nov 09, 2015, 22:05 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas to Acquire Ocata Therapeutics

 Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Ocata Therapeutics, Inc. (NASDAQ: OCAT, President and...

Oct 28, 2015, 08:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world

Astellas Inititaties Phase 3 Registration Trial of gilteritinib (ASP2215) in Relapsed or Refractory Acute Myeloid Leukemia Patients

 Astellas Pharma Inc. (TSE: 4503) today announced dosing of the first patient in a randomized Phase 3 registration trial of gilteritinib...

Oct 09, 2015, 08:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Pharma and Immunomic Therapeutics Announce Worldwide Partnership for LAMP-vax™ Products for Allergic Disease

 Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next generation vaccines based on the LAMP-vax platform, and...

Sep 16, 2015, 09:04 ET
Astellas Pharma Europe Logo

Astellas Pharma EMEA nombra a Eugene Van Rensburg responsable de finanzas

Astellas Pharma EMEA, sede central regional de Astellas Pharma Inc. para Europa, Oriente Medio y África, ha nombrado a Eugene Van Rensburg...

Sep 16, 2015, 06:43 ET
Astellas Pharma Europe Logo

Astellas Pharma EMEA nomme Eugene Van Rensburg en tant que directeur financier

Astellas Pharma EMEA, le siège régional d'Astellas Pharma Inc. pour l'Europe, le Moyen-Orient et l'Afrique, a nommé Eugene Van...

Sep 16, 2015, 06:38 ET
Astellas Pharma Europe Logo

Astellas Pharma EMEA beruft Eugene Van Rensburg zum Chief Financial Officer

Astellas Pharma EMEA, die Regionalzentrale von Astellas Pharma Inc. für Europa, den Nahen Osten und Afrika (EMEA-Wirtschaftsraum), hat...

Sep 15, 2015, 16:00 ET
Jamie McGarvey has been named senior manager, employee communications at Astellas Pharma

Jamie McGarvey joins Astellas Pharma Corporate Affairs Team

Astellas Pharma today announced that Jamie McGarvey has been named to the role of senior manager, employee communications within the Corporate...

Aug 31, 2015, 00:27 ET
Astellas Pharma Europe Logo

Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde

- Bahnbrechende Kampagne beendet die 51-jährige Wartezeit einer Frau für...

Aug 30, 2015, 09:11 ET
Astellas Pharma Europe Logo

Más de 550 mujeres mejoran su vida gracias a Action on Fistula

  - La revolucionaria campaña pone fin a los 51 años de espera de una mujer por el tratamiento quirúrgico - Las...

Aug 30, 2015, 09:09 ET
Astellas Pharma Europe Logo

Le programme Action on Fistula a déjà transformé la vie de plus de 550 femmes

  - Une campagne révolutionnaire met fin aux 51 années d'attente d'une patiente pour un traitement...

Aug 05, 2015, 09:00 ET
Australian rugby player Nick Cummins (left) promotes the #pass4prostate challenge

#pass4prostate Challenge Raises Prostate Cancer Awareness and Research Funds

 Seeking to support men and their loved ones facing the challenges that come with a diagnosis of prostate cancer, USA Rugby, the Australian...

Jun 01, 2015, 17:00 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

New Enzalutamide Data In Triple-negative Breast Cancer Presented At The 2015 American Society Of Clinical Oncology Annual Meeting

 Astellas Pharma Inc. (Tokyo: 4503) announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single...

May 30, 2015, 15:07 ET
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML)

 Astellas Pharma Inc. (TSE: 4503) today announced that preliminary data from a Phase 1/2 trial on the safety, tolerability and efficacy of...

May 26, 2015, 05:26 ET
Astellas Pharma

Astellas Pharma EMEA Celebrates Its 10th Anniversary

For the Last Decade Astellas Has Been Enhancing Patient Care & Quality of Life Throughout Europe, the Middle East and...